Plasma Levels of Antioxidant Vitamins in Patients with Acromegaly: A Case-Control Study.


Journal

Neuro endocrinology letters
ISSN: 2354-4716
Titre abrégé: Neuro Endocrinol Lett
Pays: Sweden
ID NLM: 8008373

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 15 10 2019
accepted: 12 12 2019
pubmed: 19 4 2020
medline: 22 9 2020
entrez: 19 4 2020
Statut: ppublish

Résumé

The aim of this study was to compare antioxidant vitamin C and vitamin E levels in the non-acromegaly control group and in patients with acromegaly with and without remission. In this study, 100 cases, acromegaly patients of 57% (n=57, 29F, 28M, mean ages of 49.5±12.1) and control subjects of 43% (n=43, 29F, 14M, mean ages of 49.6±9.2). Acromegaly patients were classified into two groups; active acromegaly (AA; n=33) and controlled acromegaly (CA; n=24). Vitamin C levels were significantly lower in the acromegaly group [7.6 (4.7) mg/L, as median (IQR)] when compared to the control group [12.2 (5.5) mg/L, as median (IQR)] (p <0.001). Vitamin E levels didn't show a significant difference between the acromegaly and the control groups (14.2±3.6 vs. 14.8±3.7, as mean±SD, respectively, p = 0.439). Correlation analysis showed that vitamin C levels were not significantly associated with clinical, anthropometric and laboratory parameters in the acromegaly group. Vitamin E levels were significantly associated with the total cholesterol, triglyceride, LDL-C, HDL-C, APO A1, APO B both in the acromegaly and the control groups. This study is the first one to investigate the relationship between the levels of vitamin C & E and anthropometric & metabolic parameters in acromegaly patients and control group. In our study, vitamin C level was significantly lower in the acromegaly group compared to the level in the control group. There was no significant difference in vitamin E levels between the acromegaly and control group.

Identifiants

pubmed: 32304366
pii: NEL407819C01

Substances chimiques

Apolipoprotein A-I 0
Apolipoproteins B 0
Cholesterol, HDL 0
Cholesterol, LDL 0
Receptors, Somatotropin 0
Triglycerides 0
Human Growth Hormone 12629-01-5
Vitamin E 1406-18-4
Insulin-Like Growth Factor I 67763-96-6
Cholesterol 97C5T2UQ7J
pegvisomant N824AOU5XV
Ascorbic Acid PQ6CK8PD0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

308-314

Auteurs

Nilufer Ozdemir Kutbay (N)

Celal Bayar University Faculty of Medicine, Division of Endocrinology and Metabolism, Manisa, Turkey.

Banu Sarer Yurekli (B)

Ege University Faculty of Medicine, Division of Endocrinology and Metabolism, Izmir, Turkey.

Ilgin Yildirim Simsir (I)

Ege University Faculty of Medicine, Division of Endocrinology and Metabolism, Izmir, Turkey.

Asli Suner (A)

Ege University Faculty of Medicine, Department of Biostatistics and Medical Informatics, Izmir, , Turkey.

Selda Seckiner (S)

Ege University Faculty of Medicine, Department of Nutrition and Dietetics, Izmir, Turkey.

Ozge Kucukerdonmez (O)

Ege University Faculty of Medicine, Department of Nutrition and Dietetics, Izmir, Turkey.

Fusun Saygili (F)

Ege University Faculty of Medicine, Division of Endocrinology and Metabolism, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH